European Health Technology Assessment (EU HTA)
Ecker T. 1, Barz V. 1, Redmond S. 2, Zacho J. 3, Ertl A. 4, Theuillon T. 5, Ariznavarreta Martin A. 6, Vansieleghem S. 7, Seweryn M. 8, Lidonnici D. 9, Chatzikou M. 10, Leismann J. 1
1 Ecker + Ecker GmbH, Hamburg, Germany, 2 Salutem Insights Ltd, Dublin, Ireland, 3 Zealth ApS, Copenhagen, Denmark, 4 Krammer, Wrbka & Partner Consulting GmbH, Vienna, Austria, 5 CEMKA, Bourg-la-Reine, France, 6 Outcomes’10, Castellón de la Plana, CS, Spain, 7 Hebias bv, Ronse, Belgium, 8 EconMed IT, Wola Zachariaszowska, Poland, 9 More Than Access Srl SB, Milano, Italy, 10 PharmEcons Easy Access Ltd., Rafina, Greece
“Challenges of the PICO Scoping Process: How does the number of involved member states impact results?“
Poster presentation at ISPOR Europe, November 2024
Ecker, Thomas; Barz, Vivien; Leismann, Janine
„Addressing all PICOs in the JCA dossier – Is it feasible?“
Poster presentation at ISPOR Europe, November 2024
Ecker, Thomas
“EU HTA and Stakeholder Management - Be aware of pitfalls"
EU HTA Editorial, November 2024
Ecker, Thomas (Editor)
"EU HTA 101- How to prepare for European Health Technology Assessment"
tredition, Ahrensburg, 2023
Ecker, Thomas; Huraskin, Danyil; Brozek, Antonia
“How to Align EU HTA with National Market Access?"
Poster presentation at ISPOR Europe, November 2023
Ecker, Thomas; Ecker, Christof; Oldeland, Jens
“Similarity of guidelines for direct and indirect comparisons under EUnetHTA and country-specific HTA – implications for supportive agents"
Poster presentation at ISPOR Europe, November 2023
Ecker, Thomas; Le Mao, Julie; Prada, Mariangela; Lizán, Luis; Flenner, Frederik; Brozek, Antonia
“Scoping Mock-Up: What Can We Learn From an EU-4 Experiment for EU HTA?"
Poster presentation at ISPOR Europe, November 2023
Ecker, Thomas; Ritz-Jansen, Katja; Brozek, Antonia; Ahrens, Lucas; Marx, Elisabeth
“Implications of EU HTA on Future Relevance of Surrogate Outcomes in National Assessment"
Poster presentation at ISPOR Europe, November 2023
Ecker, Thomas; Le Mao, Julie; Prada, Mariangela; Aceituno Mata, Susana; Moeller, Barbara; Huraskin, Danyil
“Are There Any Common Denominators for Early Access Programs in Europe"
Poster presentation at ISPOR Europe, November 2023
Ecker, Thomas; Le Mao, Julie; Rossi, Letizia; Ariznavarreta, Asís; Moeller, Barbara; Erni, Petra; Henkel, Pia
“ATMPs in Europe - Do We Have an Access Gap?"
Poster presentation at ISPOR Europe, November 2023
Ecker, Thomas; Kandola, Suki; Ritz-Jansen, Katja; Brozek, Antonia; Ahrens, Lucas; Marx, Elisabeth
"Implications of EU-HTA on Future Relevance of Real-World Data in National Assessments"
Poster presentation at ISPOR Boston, May 2023
Ahrens, Lucas; Marx, Elisabeth; Stengel, Stephanie; Ecker, Thomas
"EU-HTA in 2025: Industry's Stake in the Scoping Process"
Poster presentation at ISPOR Boston, May 2023
Ecker, Thomas; Kandola, Suki; Musiolik, Katharina; Ritz-Jansen, Katja; Brozek, Antonia; Ahrens, Lucas; Marx, Elisabeth
"Implications of EU-HTA on Acceptance of Indirect Treatment Comparisons in National Assessments"
Poster presentation at ISPOR Boston, May 2023
Ecker + Ecker comments on the current EUnetHTA 21 guideline Interaction between Health Technology Developer and HTA bodies (D7.1.1).
August 2022
Ecker + Ecker comments on the current EUnetHTA 21 guidelines Applicability of Evidence (D4.5), Validity of Clinical Studies (D4.6) and Guidance for JCA Submission Dossier Template (D5.1)
August 2022
Ecker + Ecker comments on the current EUnetHTA 21 scoping process guideline (D4.2).
May 2022
Ecker + Ecker comments on the current EUnetHTA 21 methodological guideline on direct and indirect comparisons (D4.3.2).
May 2022
Ecker + Ecker comments on the current EUnetHTA guideline on information retrieval.
September 2019
Ecker, Thomas; Baecke, Verena
"Mandatory Joint Clinical Assessment – What is the additional insight from EUnetHTA vs. EMA?"
Poster presentation at ISPOR Europe, November 2018